 OUTLINE: This is a randomized, multicenter study. Patients are stratified according to T stage T1 vs T2-3, number of involved mediastinal lymph nodes 1 vs 2 or more vs not evaluable, and nodal micrometastases vs clinically involved nodes mN2 vs cN2. 